{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:40:48Z","timestamp":1770270048980,"version":"3.49.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.neulet.2021.135746","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T19:37:40Z","timestamp":1613677060000},"page":"135746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Minireview: Mas-related G protein-coupled receptor X2 activation by therapeutic drugs"],"prefix":"10.1016","volume":"751","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-3598","authenticated-orcid":false,"given":"Benjamin D.","family":"McNeil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2021.135746_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128951","article-title":"RNA-seq analysis of human trigeminal and dorsal root ganglia with a focus on chemoreceptors","volume":"10","author":"Flegel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2021.135746_bib0010","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/j.pain.0000000000001217","article-title":"Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq-based resource for pain and sensory neuroscience research","volume":"159","author":"Ray","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neulet.2021.135746_bib0015","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1182\/blood-2013-02-483792","article-title":"Redefinition of the human mast cell transcriptome by deep-CAGE sequencing","volume":"123","author":"Motakis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.neulet.2021.135746_bib0020","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","article-title":"Proteinase-activated Receptor-2 mediates itch: a novel pathway for pruritus in human skin","volume":"23","author":"Steinhoff","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2021.135746_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1742-7843.2006.pto_465.x","article-title":"The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin","volume":"99","author":"Hasbak","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neulet.2021.135746_bib0030","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/all.14213","article-title":"The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: expression and function","volume":"75","author":"Wedi","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.neulet.2021.135746_bib0035","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/all.14252","article-title":"Surface expression of MRGPRX2 on resting basophils: an area of controversy","volume":"75","author":"Sabato","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.neulet.2021.135746_bib0040","doi-asserted-by":"crossref","first-page":"D780","DOI":"10.1093\/nar\/gky1020","article-title":"Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans","volume":"47","author":"Choi","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neulet.2021.135746_bib0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0750-7658(05)81020-2","article-title":"Mechanisms of activation of human mast cells and basophils by general anesthetic drugs","volume":"12","author":"Marone","year":"1993","journal-title":"Ann. Fr. Anesth. Reanim."},{"key":"10.1016\/j.neulet.2021.135746_bib0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01964946","article-title":"Functional differences between human cutaneous mast cells and basophils: a comparison of morphine-induced histamine release","volume":"18","author":"Ebertz","year":"1986","journal-title":"Agents Actions"},{"key":"10.1016\/j.neulet.2021.135746_bib0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2044.1993.tb06785.x","article-title":"Histamine release by morphine and diamorphine in man","volume":"48","author":"Withington","year":"2007","journal-title":"Anaesthesia"},{"key":"10.1016\/j.neulet.2021.135746_bib0060","doi-asserted-by":"crossref","first-page":"44400","DOI":"10.1074\/jbc.M302456200","article-title":"MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion","volume":"278","author":"Robas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2021.135746_bib0065","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbrc.2005.03.088","article-title":"Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides","volume":"330","author":"Kamohara","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2021.135746_bib0070","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbrc.2006.08.177","article-title":"Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors","volume":"349","author":"Tatemoto","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2021.135746_bib0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2021.135746_bib0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","article-title":"In silico design of novel probes for the atypical opioid receptor MRGPRX2","volume":"13","author":"Lansu","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neulet.2021.135746_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.547","article-title":"MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions","volume":"7","author":"Grimes","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.neulet.2021.135746_bib0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0095","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1021\/acs.jpcb.6b05604","article-title":"Polyarginine interacts more strongly and cooperatively than polylysine with phospholipid bilayers","volume":"120","author":"Robison","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.neulet.2021.135746_bib0100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1021\/jm00273a026","article-title":"Molecular weight studies on the active constituents of compound 48\/80","volume":"15","author":"Read","year":"1972","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2021.135746_bib0105","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/jm00269a016","article-title":"Compound 48-80. Structure-activity relations and poly-THIQ, a new, more potent analog","volume":"16","author":"Read","year":"1973","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2021.135746_bib0110","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ni.3445","article-title":"Expression profiling of constitutive mast cells reveals a unique identity within the immune system","volume":"17","author":"Dwyer","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0115","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.immuni.2019.03.013","article-title":"Activation of mast-cell-Expressed mas-related G-Protein-Coupled receptors drives non-histaminergic itch","volume":"50","author":"Meixiong","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.neulet.2021.135746_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72819-5","article-title":"Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions","volume":"10","author":"Hamamura-Yasuno","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2021.135746_bib0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/all.13301","article-title":"Allergic Fc\u03b5RI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF","volume":"73","author":"Babina","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.neulet.2021.135746_bib0130","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00299","article-title":"Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function","volume":"13","author":"Varricchi","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neulet.2021.135746_bib0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-017-0698-3","article-title":"Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1","volume":"19","author":"Manorak","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.neulet.2021.135746_bib0140","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/all.14084","article-title":"Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma","volume":"75","author":"An","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.neulet.2021.135746_bib0145","article-title":"MRGPRX2 is the codeine receptor of human skin mast cells: desensitization via \u03b2-arrestin and lack of correlation with the Fc\u03b5RI pathway","author":"Babina","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neulet.2021.135746_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-related g protein-coupled Receptor-X2 (MRGPRX2) in drug hypersensitivity reactions","volume":"9","author":"Porebski","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0155","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/bph.13509","article-title":"GPCRdb: the G protein-coupled receptor database - an introduction","volume":"173","author":"Munk","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2021.135746_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2020.05.046","article-title":"Association between mutated Mas-related G protein-coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis","author":"Suzuki","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/cells10010156","article-title":"MRGPRX2 activation by rocuronium: insights from studies with human skin mast cells and missense variants","volume":"10","author":"Ayudhya","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neulet.2021.135746_bib0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4049\/jimmunol.1701793","article-title":"Naturally occurring missense MRGPRX2 variants display loss of function phenotype for mast cell degranulation in response to substance P, Hemokinin-1, human \u03b2-defensin-3, and icatibant","volume":"201","author":"Alkanfari","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0175","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.3390\/ijms20215247","article-title":"Identification of gain and loss of function missense variants in MRGPRX2\u2019s transmembrane and intracellular domains for mast cell activation by substance P","volume":"20","author":"Chompunud Na Ayudhya","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2021.135746_bib0180","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4049\/jimmunol.1801227","article-title":"Angiogenic host defense peptide AG-30\/5C and bradykinin B2 receptor antagonist icatibant are g protein biased agonists for MRGPRX2 in mast cells","volume":"202","author":"Roy","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: from simple switches to allosteric microprocessors","volume":"17","author":"Smith","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neulet.2021.135746_bib0190","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.bja.2019.01.031","article-title":"Molecular mechanisms and pathophysiology of perioperative hypersensitivity and anaphylaxis: a narrative review","volume":"123","author":"Ebo","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bja.2018.04.001","article-title":"Anaesthesia, surgery, and life-threatening allergic reactions: protocol and methods of the 6th National Audit Project (NAP6) of the Royal College of Anaesthetists","volume":"121","author":"Cook","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/ACO.0000000000000857","article-title":"Perioperative anaphylaxis: diagnostic challenges and management","volume":"33","author":"Savic","year":"2020","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.neulet.2021.135746_bib0205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2021.135746_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100080","article-title":"IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper","volume":"13","author":"Ansotegui","year":"2020","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.neulet.2021.135746_bib0215","doi-asserted-by":"crossref","DOI":"10.1111\/all.14603","article-title":"Advances and novel developments in drug hypersensitivity diagnosis","author":"Ariza","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.neulet.2021.135746_bib0220","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40268-017-0176-x","article-title":"In vitro diagnosis of immediate drug hypersensitivity anno 2017: potentials and limitations","volume":"17","author":"Decuyper","year":"2017","journal-title":"Drugs R."},{"key":"10.1016\/j.neulet.2021.135746_bib0225","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2018.09.034","article-title":"Rocuronium hypersensitivity: does off-target occupation of the MRGPRX2 receptor play a role?","volume":"7","author":"Van Gasse","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.neulet.2021.135746_bib0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.neulet.2021.135746_bib0235","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/ACI.0000000000000665","article-title":"Adverse reactions to vancomycin and cross-reactivity with other antibiotics","volume":"20","author":"De Luca","year":"2020","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0240","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/AAC.34.5.765","article-title":"Comparison of vancomycin- and teicoplanin-induced histamine release and \"red man syndrome","volume":"34","author":"Sahai","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neulet.2021.135746_bib0245","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.36.6.1204","article-title":"Absence of \u201cred man syndrome\u201d in patients being treated with vancomycin or high-dose teicoplanin","volume":"36","author":"Rybak","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neulet.2021.135746_bib0250","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00000542-199809000-00010","article-title":"Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions","volume":"89","author":"Renz","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neulet.2021.135746_bib0255","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.37.10.2139","article-title":"Vancomycin skin tests and prediction of \u201cred man syndrome\u201d in healthy volunteers","volume":"37","author":"Polk","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neulet.2021.135746_bib0260","article-title":"Brief communication: MRGPRX2, atopic dermatitis and red man syndrome","volume":"2","author":"Azimi","year":"2017","journal-title":"Itch (Phila.)"},{"key":"10.1016\/j.neulet.2021.135746_bib0265","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1208\/pt070105","article-title":"Reformulation of a new vancomycin analog: an example of the importance of buffer species and strength","volume":"7","author":"Johnson","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.neulet.2021.135746_bib0270","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2021.135746_bib0275","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1600-0625.2010.01103.x","article-title":"Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells - drastically reduced levels of tryptase and chymase in mast cell lines","volume":"19","author":"Guhl","year":"2010","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.neulet.2021.135746_bib0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000365729","article-title":"A ten-year retrospective analysis of the distribution, use and phenotypic characteristics of the LAD2 human mast cell line","volume":"164","author":"Kirshenbaum","year":"2014","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0285","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2567.2007.02705.x","article-title":"Neuropeptides activate human mast cell degranulation and chemokine production","volume":"123","author":"Kulka","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.neulet.2021.135746_bib0290","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000542-200004000-00026","article-title":"Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells","volume":"92","author":"Veien","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neulet.2021.135746_bib0295","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00000542-198707000-00026","article-title":"Histamine release by vancomycin: a mechanism for hypotension in man","volume":"67","author":"Levy","year":"1987","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neulet.2021.135746_bib0300","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/j.1552-4604.1988.tb05737.x","article-title":"Glycopeptide antibiotics","volume":"28","author":"Parenti","year":"1988","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neulet.2021.135746_bib0305","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1128\/AAC.00341-09","article-title":"Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis","volume":"53","author":"Svetitsky","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neulet.2021.135746_bib0310","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.neulet.2021.135746_bib0315","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0149-2918(04)90170-1","article-title":"Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies","volume":"26","author":"Ball","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neulet.2021.135746_bib0320","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2340\/00015555-0650","article-title":"Drug-induced pruritus: a review","volume":"89","author":"Reich","year":"2009","journal-title":"Acta Dermato Venereol."},{"key":"10.1016\/j.neulet.2021.135746_bib0325","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11255-017-1507-0","article-title":"Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg\/day) or conventional intravenous\/oral levofloxacin (500 mg\/day): prospective, open-label, randomized, controlled, multicenter, non-i","volume":"49","author":"Ren","year":"2017","journal-title":"Int. Urol. Nephrol."},{"issue":"Suppl D","key":"10.1016\/j.neulet.2021.135746_bib0330","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jac\/18.SD.187","article-title":"Ciprofloxacin: an overview of adverse experiences","volume":"18","author":"Ball","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.neulet.2021.135746_bib0335","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89362","article-title":"Dual action of neurokinin-1 antagonists on Mas-related GPCRs","volume":"1","author":"Azimi","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.neulet.2021.135746_bib0340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.intimp.2019.02.001","article-title":"Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent","volume":"70","author":"Liu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neulet.2021.135746_bib0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14224-z","article-title":"Use of the relative release index for histamine in LAD2 cells to evaluate the potential anaphylactoid effects of drugs","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2021.135746_bib0350","article-title":"MRGPRX2 and immediate drug hypersensitivity: insights from cultured human mast cells","volume":"31","author":"Elst","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0355","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/ci300046g","article-title":"chemicalize.org","volume":"52","author":"Swain","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.neulet.2021.135746_bib0360","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc3995","article-title":"Toxicity of polymyxins: a systematic review of the evidence from old and recent studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.neulet.2021.135746_bib0365","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.112.4.571","article-title":"Mast cell degranulation and histamine release observed in a new in vitro system","volume":"112","author":"Lagunoff","year":"1960","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2021.135746_bib0370","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cbi.2019.05.014","article-title":"Polymyxin B and polymyxin E induce anaphylactoid response through mediation of Mas-related G protein-coupled receptor X2","volume":"308","author":"Zhan","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neulet.2021.135746_bib0375","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/bja\/87.5.755","article-title":"Structure, conformation, and action of neuromuscular blocking drugs \u2020","volume":"87","author":"Lee","year":"2001","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0380","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2044.2008.05866.x","article-title":"The undesirable effects of neuromuscular blocking drugs","volume":"64","author":"Claudius","year":"2009","journal-title":"Anaesthesia"},{"key":"10.1016\/j.neulet.2021.135746_bib0385","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2165\/00003495-199753050-00012","article-title":"Cisatracurium besilate","volume":"53","author":"Bryson","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.neulet.2021.135746_bib0390","first-page":"1010","article-title":"A two-center comparison of the cardiovascular effects of cisatracurium (Nimbex trademmark) and vecuronium in patients with coronary artery disease","volume":"81","author":"Konstadt","year":"1995","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neulet.2021.135746_bib0395","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.intimp.2018.07.020","article-title":"Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2","volume":"62","author":"Che","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neulet.2021.135746_bib0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cellimm.2018.08.005","article-title":"Mivacurium induce mast cell activation and pseudo-allergic reactions via MAS-related G protein coupled receptor-X2","volume":"332","author":"Che","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0405","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF01988720","article-title":"Wheal and flare responses to muscl relaxants in humans","volume":"34","author":"Levy","year":"1991","journal-title":"Agents Actions"},{"key":"10.1016\/j.neulet.2021.135746_bib0410","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/bja\/85.6.844","article-title":"Weal and flare responses to intradermal rocuronium and cisatracurium in humans","volume":"85","author":"Levy","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0415","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1034\/j.1399-6576.2003.00093.x","article-title":"Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique*","volume":"47","author":"Berg","year":"2003","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.neulet.2021.135746_bib0420","article-title":"MRGPRX2 activation causes increased skin reactivity in chronic spontaneous urticaria patients","author":"Shtessel","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neulet.2021.135746_bib0425","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-200161070-00003","article-title":"Newer neuromuscular blocking agents","volume":"61","author":"Sparr","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.neulet.2021.135746_bib0430","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2044.1991.tb09539.x","article-title":"The neuromuscular blocking effect of Org 9426","volume":"46","author":"Booij","year":"1991","journal-title":"Anaesthesia"},{"key":"10.1016\/j.neulet.2021.135746_bib0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03013252","article-title":"Haemodynamic effects of rocuronium bromide in adult cardiac surgical patients","volume":"45","author":"Hudson","year":"1998","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0440","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/bja\/77.5.607","article-title":"Effects of rocuronium and vecuronium on intracranial pressure, mean arterial pressure and heart rate in neurosurgical patients","volume":"77","author":"Schramm","year":"1996","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0445","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF03009764","article-title":"Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium","volume":"40","author":"McCoy","year":"1993","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0450","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/bja\/aes506","article-title":"Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011","volume":"110","author":"Sadleir","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neulet.2021.135746_bib0455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ALN.0000000000000512","article-title":"Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium","volume":"122","author":"Reddy","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neulet.2021.135746_bib0460","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0310057X1204000204","article-title":"Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two","volume":"40","author":"Baldo","year":"2012","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.neulet.2021.135746_bib0465","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2011.08.043","article-title":"Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2021.135746_bib0470","doi-asserted-by":"crossref","first-page":"30290","DOI":"10.1074\/jbc.270.51.30290","article-title":"Presence of the \u03bc3Opiate receptor in endothelial cells","volume":"270","author":"Stefano","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2021.135746_bib0475","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.4049\/jimmunol.1801423","article-title":"A mast cell\u2013Specific receptor is critical for granuloma induced by intrathecal morphine infusion","volume":"203","author":"Zhang","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0480","first-page":"216","article-title":"Morphine is an exogenous ligand for MrgX2, a G protein-coupled receptor for cortistatin","volume":"3","author":"Akuzawa","year":"2009","journal-title":"J. Cell Anim. Biol."},{"key":"10.1016\/j.neulet.2021.135746_bib0485","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/jphp.13009","article-title":"Relationship between MRGPRX2 and pethidine hydrochloride- or fentanyl citrate-induced LAD2 cell degranulation","volume":"70","author":"Liu","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neulet.2021.135746_bib0490","series-title":"Role of Meningeal Mast Cells in Intrathecal Morphine\u2013evoked Granuloma Formation.","first-page":"664","author":"Yaksh","year":"2013"},{"key":"10.1016\/j.neulet.2021.135746_bib0495","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/pme.12666","article-title":"The relationship between the mechanisms of action and safety profiles of intrathecal morphine and ziconotide: a review of the literature","volume":"16","author":"Webster","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.neulet.2021.135746_bib0500","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1213\/ANE.0000000000003887","article-title":"Side effect rates of opioids in equianalgesic doses via intravenous patient-controlled analgesia: a systematic review and network meta-analysis","volume":"129","author":"Dinges","year":"2019","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neulet.2021.135746_bib0505","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2230.2009.03463.x","article-title":"Opioid-induced pruritus: an update","volume":"35","author":"Reich","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.neulet.2021.135746_bib0510","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0625.2011.01410.x","article-title":"Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H1-antihistamines","volume":"21","author":"Maurer","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.neulet.2021.135746_bib0515","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/pcan.2011.50","article-title":"Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer","volume":"15","author":"Spitz","year":"2012","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.neulet.2021.135746_bib0520","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1185\/03007990903328959","article-title":"From somatostatin to octreotide LAR: evolution of a somatostatin analogue","volume":"25","author":"Anthony","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neulet.2021.135746_bib0525","first-page":"1189","article-title":"Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy","volume":"81","author":"Thorner","year":"1996","journal-title":"Geref International Study Group. The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.neulet.2021.135746_bib0530","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0090-8258(03)00408-6","article-title":"Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer","volume":"90","author":"Verschraegen","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.neulet.2021.135746_bib0535","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/JLB.2AB1018-405R","article-title":"Novel MRGPRX2 antagonists inhibit IgE\u2010independent activation of human umbilical cord blood\u2010derived mast cells","volume":"106","author":"Ogasawara","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neulet.2021.135746_bib0540","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/eji.201746951","article-title":"Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2","volume":"47","author":"Zhang","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neulet.2021.135746_bib0545","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/adc.67.1_Spec_No.57","article-title":"Pharmacokinetics and antibacterial activity of daily gentamicin","volume":"67","author":"Skopnik","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.neulet.2021.135746_bib0550","article-title":"Peptides of major basic protein and eosinophil cationic protein activate human mast cells","volume":"21","author":"Ogasawara","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.neulet.2021.135746_bib0555","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/molecules25051028","article-title":"Protective effect of genistein against compound 48\/80 induced anaphylactoid shock via inhibiting MAS related g protein-coupled receptor X2 (MRGPRX2)","volume":"25","author":"Kumar","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neulet.2021.135746_bib0560","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.intimp.2018.11.025","article-title":"Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLC\u03b3-IP3R related Ca2+ fluctuations","volume":"66","author":"Ding","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neulet.2021.135746_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173104","article-title":"A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis","volume":"878","author":"Suzuki","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2021.135746_bib0570","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2018.04.004","article-title":"Anti-pseudo-allergy effect of isoliquiritigenin is MRGPRX2-dependent","volume":"198","author":"Hou","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.neulet.2021.135746_bib0575","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/ptr.6615","article-title":"The anti\u2010anaphylactoid effects of Piperine through regulating MAS\u2010related G protein\u2010coupled receptor X2 activation","volume":"34","author":"Qiao","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.neulet.2021.135746_bib0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153149","article-title":"Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue","volume":"68","author":"Wang","year":"2020","journal-title":"Phytomedicine"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021001245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021001245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:38:50Z","timestamp":1759610330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021001245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":116,"alternative-id":["S0304394021001245"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135746","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minireview: Mas-related G protein-coupled receptor X2 activation by therapeutic drugs","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"135746"}}